參考資料
Zhang, M., Zhang, C., Zhao, J., Zhang, H., Zhai, Q., & Chen, W. (2020). Meta-analysis of the efficacy of probiotic-supplemented therapy on the eradication of H. pylori and incidence of therapy-associated side effects. Microbial pathogenesis, 147, 104403. https://doi.org/10.1016/j.micpath.2020.104403
Wang, Y., Wang, X., Cao, X. Y., Zhu, H. L., & Miao, L. (2023). Comparative effectiveness of different probiotics supplements for triple helicobacter pylori eradication: a network meta-analysis. Frontiers in cellular and infection microbiology, 13, 1120789. https://doi.org/10.3389/fcimb.2023.1120789
Yang, Z., Zhou, Y., Han, Z., He, K., Zhang, Y., Wu, D., & Chen, H. (2024). The effects of probiotics supplementation on Helicobacter pylori standard treatment: an umbrella review of systematic reviews with meta-analyses. Scientific reports, 14(1), 10069. https://doi.org/10.1038/s41598-024-59399-4
Shi, X., Zhang, J., Mo, L., Shi, J., Qin, M., & Huang, X. (2019). Efficacy and safety of probiotics in eradicating Helicobacter pylori: A network meta-analysis. Medicine, 98(15), e15180. https://doi.org/10.1097/MD.0000000000015180
Li, M., & Xie, Y. (2025). Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis. Frontiers in cellular and infection microbiology, 15, 1441185. https://doi.org/10.3389/fcimb.2025.1441185
Li, M., Wang, X., Dong, X., Teng, G., Dai, Y., & Wang, W. (2024). Lactobacillus reuteri compared with placebo as an adjuvant in Helicobacter pylori eradication therapy: a meta-analysis of randomized controlled trials. Therapeutic advances in gastroenterology, 17, 17562848241258021. https://doi.org/10.1177/17562848241258021
Tanashat, M., Abuelazm, M., Abouzid, M., Al-Ajlouni, Y. A., Ramadan, A., Alsalah, S., Sharaf, A., Ayman, D., Elharti, H., Zhana, S., Altobaishat, O., Abdelazeem, B., & Jaber, F. (2025). Efficacy of probiotics regimens for Helicobacter pylori eradication: A systematic review, pairwise, and network meta-analysis of randomized controlled trials. Clinical nutrition ESPEN, 65, 424–444. https://doi.org/10.1016/j.clnesp.2024.11.016
延伸閱讀
更多 實證文章
從保健食品實證到藥學人文,繼續探索其他文章。

保健食品實證
2025年12月8日
GRAS vs NDI
GRAS(Generally Recognized as Safe,一般公認安全)
閱讀全文

保健食品實證
2025年11月8日
認識特定疾病配方食品 - PART 7
走到這篇,算是為本系列文章劃下階段性的結尾。雖然本系列已經來到第七篇,但「特定疾病配方食品」的領域其實遠比想像中更廣、更深。在臨床照護上,…
閱讀全文

藥學人文
2025年11月7日
第一眼看到這張圖,你會懷疑是AI生成的嗎?
2013年,我踏上了環遊世界的旅程,開啟了改變我人生的奇妙一年。
閱讀全文

保健食品實證
2025年11月7日
認識特定疾病配方食品 - PART 6
《腫瘤配方》
閱讀全文

保健食品實證
2025年10月12日
認識特定疾病配方食品 - PART 3
前兩篇我們認識的特定疾病配方食品的法規定義與成分解析,這篇開始帶大家剖析市售配方。但在開始前我們先複習一下:
閱讀全文

保健食品實證
2025年10月12日
認識特定疾病配方食品 - PART 4
【糖尿病配方天天喝穩定血糖?小心喝錯配方反而提高膽固醇!】
閱讀全文
